Table 2.
Characteristic | All patients (n = 856) | |||||||
---|---|---|---|---|---|---|---|---|
Univariate logistic regression | Multivariate logistic regression analysis with backward selection | |||||||
hsCRP < 2 mg/l (n = 491) (%) | hsCRP ≥ 2 mg/l (n = 356) (%) | Odds ratio | p value | Odds ratio | p value | 95% CI | ||
Female sex | 27 | 27 | 0.97 | 0.83 | ||||
Age > 75 yrs | 45 | 42 | 0.90 | 0.43 | ||||
Lipoprotein (a) > 30 mg/dl | 28 | 34 | 1.34 | 0.05 | 1.61 | 0.048 | 1.00 | 2.57 |
LDL-cholesterol > 70 mg/dl | 67 | 79 | 1.84 | < 0.001 | ||||
HbA1c > 6.5% | 18 | 22 | 1.33 | 0.10 | ||||
proBNP > 500 pg/ml | 37 | 60 | 1.55 | < 0.001 | 2.57 | < 0.001 | 1.64 | 4.02 |
Hypertension | 80 | 81 | 1.06 | 0.73 | ||||
Diabetes | 26 | 32 | 1.38 | 0.03 | ||||
Smoking | 35 | 48 | 1.71 | < 0.001 | 1.70 | 0.022 | 1.08 | 2.70 |
BMI > 30 kg/m2 | 13 | 26 | 2.29 | < 0.001 | 2.28 | 0.007 | 1.26 | 4.12 |
Stable CHD with revascularization procedure | 38 | 40 | 1.07 | 0.61 | ||||
History of acute coronary syndrome | 35 | 35 | 0.97 | 0.81 | ||||
No statin | 20 | 30 | 1.76 | < 0.001 | ||||
Statin low dose | 26 | 25 | 0.93 | 0.64 | ||||
Statin high dose | 54 | 45 | 0.69 | 0.009 | ||||
Ezetimibe | 24 | 14 | 0.53 | 0.001 | 0.51 | 0.014 | 0.30 | 0.87 |
PSCK9-inhibitor | 1 | 1 | 1.34 | 0.72 | ||||
Metabolic syndrome | 23 | 5 | 0.17 | < 0.001 |